Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
British Journal of Cancer
|
September 19, 2007
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
C Massard, J-J Voigt, A Laplanche, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial
M Gross-Goupil, A Fourcade, E Blot, et al.
British Journal of Cancer
|
August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
R Bugat, A Bataillard, T Lesimple, et al.
The Journal of Urology
|
August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
B Escudier, J P Droz, F Rolland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
M De Santis, P J Wiechno, J Bellmunt, et al.
BMC Medical Education
|
January 17, 2018
Choosing a career in oncology: results of a nationwide cross-sectional study
J C Faivre, J E Bibault, A Bellesoeur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
J-P Lotz, B Bui, F Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
T Murez, X Durand, M Rivoire, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2017
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
Y Loriot, L Pagliaro, A Fléchon, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
British Journal of Cancer
|
September 19, 2007
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
C Massard, J-J Voigt, A Laplanche, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial
M Gross-Goupil, A Fourcade, E Blot, et al.
British Journal of Cancer
|
August 14, 2003
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
R Bugat, A Bataillard, T Lesimple, et al.
The Journal of Urology
|
August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
B Escudier, J P Droz, F Rolland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)
M De Santis, P J Wiechno, J Bellmunt, et al.
BMC Medical Education
|
January 17, 2018
Choosing a career in oncology: results of a nationwide cross-sectional study
J C Faivre, J E Bibault, A Bellesoeur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
J-P Lotz, B Bui, F Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy
P Rougier, R Bugat, J Y Douillard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
T Murez, X Durand, M Rivoire, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 18, 2017
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
Y Loriot, L Pagliaro, A Fléchon, et al.
Page
of 19